Cumulative incidence of metachronous colorectal cancer - PubMed (original) (raw)
Cumulative incidence of metachronous colorectal cancer
R L Cali et al. Dis Colon Rectum. 1993 Apr.
Abstract
The incidence of metachronous colorectal cancer has most often been reported as a crude rate: second cancers/index cancers. The reported incidence varies between 0.5 percent and 3.6 percent. However, these calculations do not take into account factors such as length of survival and length of follow-up. The cumulative incidence more accurately reflects the risk for developing a metachronous cancer and was determined in a retrospective analysis of 5,476 patients who were diagnosed with colon or rectal cancer between 1965 and 1985. The cumulative probability was calculated by determining the number of patients developing a metachronous colon cancer vs. the number remaining at risk at that point in time. The calculated annual incidence for metachronous tumors was 0.35 percent per year. The cumulative incidence at 18 years was 6.3 percent. Analysis also demonstrated that metachronous cancers were diagnosed at earlier stages than were index cancers (P = 0.03). Subgroup analysis was performed on patients diagnosed with metachronous cancer before and after 1980. There was a difference in the incidence of metachronous cancers between these two groups (P = 0.04).
Similar articles
- The incidence and risk factors of metachronous colorectal cancer: an indication for follow-up.
Mulder SA, Kranse R, Damhuis RA, Ouwendijk RJ, Kuipers EJ, van Leerdam ME. Mulder SA, et al. Dis Colon Rectum. 2012 May;55(5):522-31. doi: 10.1097/DCR.0b013e318249db00. Dis Colon Rectum. 2012. PMID: 22513430 - Higher incidence of metachronous advanced neoplasia in patients with synchronous advanced neoplasia and left-sided colorectal resection for colorectal cancer.
Yabuuchi Y, Imai K, Hotta K, Ito S, Kishida Y, Yamaguchi T, Shiomi A, Kinugasa Y, Yoshida M, Tanaka M, Kawata N, Kakushima N, Takizawa K, Ishiwatari H, Matsubayashi H, Ono H. Yabuuchi Y, et al. Gastrointest Endosc. 2018 Aug;88(2):348-359.e1. doi: 10.1016/j.gie.2018.03.011. Epub 2018 Mar 21. Gastrointest Endosc. 2018. PMID: 29574125 - The lifelong risk of metachronous colorectal cancer justifies long-term colonoscopic follow-up.
Bouvier AM, Latournerie M, Jooste V, Lepage C, Cottet V, Faivre J. Bouvier AM, et al. Eur J Cancer. 2008 Mar;44(4):522-7. doi: 10.1016/j.ejca.2008.01.007. Epub 2008 Feb 5. Eur J Cancer. 2008. PMID: 18255278 - Proximal location of colon cancer is a risk factor for development of metachronous colorectal cancer: a population-based study.
Gervaz P, Bucher P, Neyroud-Caspar I, Soravia C, Morel P. Gervaz P, et al. Dis Colon Rectum. 2005 Feb;48(2):227-32. doi: 10.1007/s10350-004-0805-7. Dis Colon Rectum. 2005. PMID: 15711864 - Synchronous and metachronous head and neck carcinomas.
Schwartz LH, Ozsahin M, Zhang GN, Touboul E, De Vataire F, Andolenko P, Lacau-Saint-Guily J, Laugier A, Schlienger M. Schwartz LH, et al. Cancer. 1994 Oct 1;74(7):1933-8. doi: 10.1002/1097-0142(19941001)74:7<1933::aid-cncr2820740718>3.0.co;2-x. Cancer. 1994. PMID: 8082099 Review.
Cited by
- Surveillance of patients following surgery with curative intent for colorectal cancer.
Gan S, Wilson K, Hollington P. Gan S, et al. World J Gastroenterol. 2007 Jul 28;13(28):3816-23. doi: 10.3748/wjg.v13.i28.3816. World J Gastroenterol. 2007. PMID: 17657835 Free PMC article. Review. - A retrospective study on the use of post-operative colonoscopy following potentially curative surgery for colorectal cancer in a Canadian province.
Hilsden RJ, Bryant HE, Sutherland LR, Brasher PM, Fields AL. Hilsden RJ, et al. BMC Cancer. 2004 Apr 19;4:14. doi: 10.1186/1471-2407-4-14. BMC Cancer. 2004. PMID: 15096279 Free PMC article. - Feasibility and safety of laparoscopic surgery for metachronous colorectal cancer.
Nagasaki T, Akiyoshi T, Ueno M, Fukunaga Y, Nagayama S, Fujimoto Y, Konishi T, Arai M, Yamaguchi T. Nagasaki T, et al. Surg Today. 2015 Apr;45(4):434-8. doi: 10.1007/s00595-014-0925-1. Epub 2014 May 20. Surg Today. 2015. PMID: 24840401 - Chemoprevention of colorectal cancer.
Langman M, Boyle P. Langman M, et al. Gut. 1998 Oct;43(4):578-85. doi: 10.1136/gut.43.4.578. Gut. 1998. PMID: 9824590 Free PMC article. Review. - Surveillance after curative treatment for colorectal cancer.
van der Stok EP, Spaander MCW, Grünhagen DJ, Verhoef C, Kuipers EJ. van der Stok EP, et al. Nat Rev Clin Oncol. 2017 May;14(5):297-315. doi: 10.1038/nrclinonc.2016.199. Epub 2016 Dec 20. Nat Rev Clin Oncol. 2017. PMID: 27995949 Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical